Skip to main content
Menu
Home
  • About
    • Board of Directors
    • Statement on Diversity, Equity, and Inclusion
    • Strategic Plan
    • Foundation
    • Strategic Partners
    • Mark Your Calendar
    • Contact Us
  • Membership
    • Membership Categories & Benefits
    • GAPNA Exchange Community
    • Volunteer Opportunities
    • Awards and Scholarships
    • Chapters
    • Professional Partners
    • Voices of GAPNA
  • Certification
    • Certification
    • About
    • Recertification
    • Fees
    • Exam Preparation
    • Certificant Directory
    • FAQ
  • Education
    • PharmaCon27 – Hawaii
    • ENGAGE27 - San Diego
    • Online Library
    • Leadership Institute
    • Dementia Care Specialist Course
    • PAC/LTC Workshop
    • Pharmacology Update Workshop
    • Age-Friendly Health Systems
  • Publications
    • Journal of Gerontological Nursing
    • Newsletter
    • Outside Publications
    • GAPNA Chat
    • Toolkits & Ebooks
  • Advocacy
    • Policies & Position Statements
    • Legislative Activities
    • Advocacy Briefs
    • GAPNA Health Affairs Nursing Coalitions
    • Health Affairs Toolkit

Secondary Navigation

  • Log In
  • Careers
  • Corporate
  • Join/Renew
  • Store
  • Search

Clinical Resources on Tardive Dyskinesia

Breadcrumb

  1. Home
  2. About
  3. Strategic Partners
  4. Neurocrine Biosciences Inc.
  5. Clinical Resources on Tardive Dyskinesia

Additional Resources:
 

  • Expert Consensus Recommendations for Tardive Dyskinesia in LTC Settings
  • TD Resources Toolkit 2026
  • TDAW 2026 Toolkit
  • AIMS Scorecard and Instructions
  • LTC "Blue Man" Screening Tool
  • MIND-TD Questionnaire
  • TD LTC Regulations & Clinical Guidance
  • TD Screening & Treatment Recommendations
  • The AIMS: What, Why, When, and How
  • Discover DIMD
  • Bringing TD Frontline
  • TD Screening Toolkit
  • Inappropriate Anticholinergic Use in TD
  • TD Treatment Toolkit
  • 4Ms Framework in LTC
  • GAPNA Chat Podcast: Treatment Approaches to TD
Share this
  • email
  • facebook
  • linkedin
  • X
ONCE-DAILY Austedo XR® (deutetrabenazine) extended-release, How do drug-drug interactions impact treatment decisions? Please see the full Prescribing Information, including Boxed Warning on www.AUSTEDOhcp.com.
Explorre Ingrezza, see full prescribing information, including boxed warning.
Raldesy. No crushing or compounded needed with Raldesy (TM) trazodone hydrochloride Oral solution.

Gerontological Advanced Practice Nurses Association (GAPNA)
866-355-1392
Contact Us: GAPNA@gapna.org

  • facebook
  • X (Twitter)
  • instagram
  • linkedin
  • youtube

Corporate Support

  • Corporate Opportunities
  • Strategic Partners

Main navigation

  • About
  • Membership
  • Certification
  • Education
  • Publications
  • Advocacy

Footer Menu

  • Privacy Policy
  • Terms & Conditions
  • Medical Disclaimer
  • Accreditation Statement
  • About
    • Board of Directors
    • Statement on Diversity, Equity, and Inclusion
    • Strategic Plan
    • Foundation
    • Strategic Partners
    • Mark Your Calendar
    • Contact Us
  • Membership
    • Membership Categories & Benefits
      • Student Membership
      • Institutional & Organizational Membership
      • Associate Membership
    • GAPNA Exchange Community
    • Volunteer Opportunities
      • Volunteer for Committees and SIGs
      • Committees
      • Special Interest Groups
      • Task Forces
    • Awards and Scholarships
      • Awards and Scholarships Recipients
    • Chapters
    • Professional Partners
    • Voices of GAPNA
  • Certification
    • Certification
    • About
    • Recertification
      • Overview
      • Recertify Through Re-Examination
      • Recertify Through Continuing Education
        • Professional Practice Hours
        • Continuing Education/ANCC Contact Hours
        • Examples of Accepted Hours
      • Submitting Your Recertification Application
    • Fees
    • Exam Preparation
    • Certificant Directory
    • FAQ
  • Education
    • PharmaCon27 – Hawaii
    • ENGAGE27 - San Diego
    • Online Library
    • Leadership Institute
    • Dementia Care Specialist Course
    • PAC/LTC Workshop
    • Pharmacology Update Workshop
    • Age-Friendly Health Systems
  • Publications
    • Journal of Gerontological Nursing
    • Newsletter
      • Contact Newsletter Editorial Staff
    • Outside Publications
    • GAPNA Chat
    • Toolkits & Ebooks
      • Gerontology Resources for APRN Preceptors and Students Toolkit
      • Gerontology Resources for APRNs in Acute and Emergent Care Settings
  • Advocacy
    • Policies & Position Statements
      • Addressing Nursing Home Safety during the COVID-19 Pandemic and Beyond
      • Clinical Practice of Gerontological Nurse Practitioners
      • GAPNA Consensus Statement on Proficiencies for the APRN Gerontological Specialist
      • GAPNA Geropschiatric Nursing Position Statement 2025
      • GAPNA Geropsychiatric Nursing Position Statement
      • GAPNA Policy Priorities
      • Joint Summary Statement - Diagnosing Schizophrenia in Skilled Nursing Centers
      • NP Organizations Concerned About DOE Negotiated Rulemaking
      • Neurological Behavior: An Educational Update
      • Nurse Practitioner DNP Education, Certification and Titling: A Unified Statement
      • Primary care in long-term care sites: Long-term care sites as appropriate clinical placements for primary care nurse practitioner students
      • Resolution on Advanced Practice Gerontological Nurse Interactions with Industry Representatives
    • Legislative Activities
    • Advocacy Briefs
    • GAPNA Health Affairs Nursing Coalitions
    • Health Affairs Toolkit